These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25775207)

  • 1. Highlights in lymphoma from the 2014 American Society of Hematology annual meeting and exposition.
    Clin Adv Hematol Oncol; 2015 Feb; 13(2 Suppl 2):1-23. PubMed ID: 25775207
    [No Abstract]   [Full Text] [Related]  

  • 2. Highlights in lymphoma from the 2016 American Society of Hematology annual meeting and exposition: Commentary.
    Horwitz SM
    Clin Adv Hematol Oncol; 2017 Feb; 15 Suppl 1(2):20-23. PubMed ID: 28590460
    [No Abstract]   [Full Text] [Related]  

  • 3. Recent advances in the treatment of leukemia, lymphoma, and myeloma. [Review of Selected Presentations From the 52nd American Society of Hematology Annual Meeting and Exposition. December 4–7, 2010. Orlando, Florida].
    Cheson BD
    Clin Adv Hematol Oncol; 2011 Apr; 9(4 Suppl 7):1-24. PubMed ID: 21558999
    [No Abstract]   [Full Text] [Related]  

  • 4. Highlights in leukemia and lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2021 Mar; 19 Suppl 11(3):1-20. PubMed ID: 33843915
    [No Abstract]   [Full Text] [Related]  

  • 5. Highlights in leukemia and lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    Barr PM
    Clin Adv Hematol Oncol; 2021 Mar; 19 Suppl 11(3):17-19. PubMed ID: 33843916
    [No Abstract]   [Full Text] [Related]  

  • 6. Highlights in Lymphoma From the 60th American Society of Hematology Annual Meeting.
    Clin Adv Hematol Oncol; 2019 Feb; 17 Suppl 4(2):1-23. PubMed ID: 31730576
    [No Abstract]   [Full Text] [Related]  

  • 7. Highlights in lymphoma from the 2012 American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2013 Feb; 11(2 Suppl 3):6-23. PubMed ID: 23604200
    [No Abstract]   [Full Text] [Related]  

  • 8. Highlights in relapsed/refractory follicular lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 2(1):1-20. PubMed ID: 33843857
    [No Abstract]   [Full Text] [Related]  

  • 9. Highlights in relapsed/refractory follicular lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    Salles G
    Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 2(1):13-16. PubMed ID: 33843858
    [No Abstract]   [Full Text] [Related]  

  • 10. Highlights in Hodgkin lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2021 Feb; 19 Suppl 7(2):1-24. PubMed ID: 33843921
    [No Abstract]   [Full Text] [Related]  

  • 11. 9th Annual International Congress on Hematologic Malignancies, Whistler, BC, Canada; 41st Annual Meeting of the American Society of Clinical Oncology, Orlando, FL; 46th Annual Meeting of the American Society of Hematology, San Diego, CA.
    Reddy GK; Tyagi P
    Clin Lymphoma; 2005 Jun; 6(1):4-10. PubMed ID: 15989700
    [No Abstract]   [Full Text] [Related]  

  • 12. Highlights in Hodgkin lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    Evens AM
    Clin Adv Hematol Oncol; 2021 Feb; 19 Suppl 7(2):20-23. PubMed ID: 33843922
    [No Abstract]   [Full Text] [Related]  

  • 13. Highlights in T-cell lymphoma from the 2011 American Society of Hematology Annual Meeting and Exposition.
    Horwitz SM
    Clin Adv Hematol Oncol; 2012 Mar; 10(3 Suppl 3):1-24. PubMed ID: 22398731
    [No Abstract]   [Full Text] [Related]  

  • 14. Highlights in T-cell lymphoma From the 2013 American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2014 Feb; 12 Suppl 5(2):6-18. PubMed ID: 25856173
    [No Abstract]   [Full Text] [Related]  

  • 15. Highlights in lymphoma from the 2013 American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2014 Feb; 12 Suppl 6(2):3-18. PubMed ID: 25856284
    [No Abstract]   [Full Text] [Related]  

  • 16. Highlights in lymphoma from the 2013 American Society of Hematology Annual Meeting and Exposition: commentary.
    Bartlett NL
    Clin Adv Hematol Oncol; 2014 Feb; 12 Suppl 6(2):18-23. PubMed ID: 25856285
    [No Abstract]   [Full Text] [Related]  

  • 17. Highlights in lymphoma from the 2017 American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2018 Feb; 16 Suppl 3(2):1-24. PubMed ID: 29742095
    [No Abstract]   [Full Text] [Related]  

  • 18. Highlights in T-cell lymphoma From the 2013 American Society of Hematology Annual Meeting and Exposition: commentary.
    Horwitz SM
    Clin Adv Hematol Oncol; 2014 Feb; 12 Suppl 5(2):19-22. PubMed ID: 25856174
    [No Abstract]   [Full Text] [Related]  

  • 19. American Society of Hematology--51st annual meeting & exposition. Part 1.
    Shumoogam J; Beecher N
    IDrugs; 2010 Feb; 13(2):57-9. PubMed ID: 20127549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New developments in the treatment of the lymphomas and leukemias. Highlights from the 40th annual meeting of the American Society of Hematology (ASH). Miami, Florida, USA. December 4-8, 1998. Abstracts.
    Oncology (Williston Park); 1999 Mar; 13(3 Suppl 1):1-56. PubMed ID: 10372205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.